- Indication
- Mucolytic
- RAG rating
- Double Red
- Document type
- Decision document
- Place
- Hertfordshire and West Essex ICB
- Output type
- Pharmacy / Prescribing
Carbocisteine 750mg/10ml oral solution S/F
HERTFORDSHIRE AND WEST ESSEX AREA PRESCRIBING COMMITTEE (HWE APC)
Carbocisteine as a mucolytic for adult patients for the treatment of respiratory tract diseases
DOUBLE RED
Not recommended for prescribing in Primary, Community, Secondary or Tertiary care.
|
Name generic (trade): |
Carbocisteine 750mg/10ml oral solution S/F |
|
What it is: |
Mucolytic in respiratory disorders |
|
Indication: |
Licensed for adults as a mucolytic agent for the treatment of respiratory tract diseases in which a reduction in bronchial secretion viscosity is required to facilitate expectoration. |
|
Date decision last revised: |
October 2025 |
HWE APC recommendation:
Carbocisteine 750mg/10ml oral solution S/F is NOT recommended for prescribing in Primary, Community, Secondary or Tertiary care due to its high cost and lower cost alternative formulations are available.
- Version number
- 1.0
- Developed by
- Pharmacy and Medicines Optimisation Team, Hertfordshire and West Essex (HWE) ICB with relevant HWE ICS stakeholders.
- Approved by
- Hertfordshire & West Essex Area Prescribing Committee
- Date approved / updated
- October 2025
- Review date
- This HWE APC recommendation is based upon the evidence available at the time of publication. This recommendation will be reviewed upon request in the light of new evidence becoming available.
- Superseded version